 "Argentina to start Covid vaccination of children aged 3-11 by end of 2021")
The Argentine National Administration of Drugs, Food and Medical Technology (ANMAT) has authorised the use of the Chinese Sinopharm vaccine against COVID-19 for children aged 3-11 years, Health Minister Carla Vizzotti said, adding that the campaign will start by the end of the year.
"ANMAT has confirmed that we can use Sinopharm [vaccine] for children aged 3-11 years ... Argentina will finish 2021 with the full coverage and protection of people aged over 3 years," Vizzotti said at a press conference on late Friday.
The minister added that there were from 5.5 to 6 million children of this age in Argentina.
Argentina has confirmed more than 5.25 million COVID-19 cases so far, with over 115,000 fatalities.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app